Book contents
- Stories of Stroke
- Stories of Stroke
- Copyright page
- Contents
- Contributors
- Why This Book Needed to Be Written
- Preface
- Part I Early Recognition
- Part II Basic Knowledge, Sixteenth to Early Twentieth Centuries
- Part III Modern Era, Mid-Twentieth Century to the Present
- Types of Stroke
- Some Key Physicians
- Imaging
- Care
- Treatment
- Chapter Forty Three Clinical Stroke Trials
- Chapter Forty Four Heparin
- Chapter Forty Five Warfarin
- Chapter Forty Six Direct Oral Anticoagulants
- Chapter Forty Seven Aspirin
- Chapter Forty Eight Other Antiplatelets
- Chapter Forty Nine Other Medical Treatments
- Chapter Fifty Neuroprotection
- Chapter Fifty One Thrombolysis
- Chapter Fifty Two Treatment of Cerebral Venous Thrombosis
- Chapter Fifty three Recovery and Rehabilitation
- Chapter Fifty Four Carotid Artery Surgery
- Chapter Fifty Five Angioplasty and Stenting
- Chapter Fifty Six Endovascular Treatment of Acute Ischemic Stroke
- Chapter Fifty Seven Brain Aneurysm Treatment
- Chapter Fifty Eight Medical and Surgical Treatments of Intracerebral Hemorrhage
- Chapter Fifty Nine Treatment of Vascular Malformations
- Part IV Stroke Literature, Organizations, and Patients
- Index
- References
Chapter Fifty Two - Treatment of Cerebral Venous Thrombosis
from Treatment
Published online by Cambridge University Press: 13 December 2022
Book contents
- Stories of Stroke
- Stories of Stroke
- Copyright page
- Contents
- Contributors
- Why This Book Needed to Be Written
- Preface
- Part I Early Recognition
- Part II Basic Knowledge, Sixteenth to Early Twentieth Centuries
- Part III Modern Era, Mid-Twentieth Century to the Present
- Types of Stroke
- Some Key Physicians
- Imaging
- Care
- Treatment
- Chapter Forty Three Clinical Stroke Trials
- Chapter Forty Four Heparin
- Chapter Forty Five Warfarin
- Chapter Forty Six Direct Oral Anticoagulants
- Chapter Forty Seven Aspirin
- Chapter Forty Eight Other Antiplatelets
- Chapter Forty Nine Other Medical Treatments
- Chapter Fifty Neuroprotection
- Chapter Fifty One Thrombolysis
- Chapter Fifty Two Treatment of Cerebral Venous Thrombosis
- Chapter Fifty three Recovery and Rehabilitation
- Chapter Fifty Four Carotid Artery Surgery
- Chapter Fifty Five Angioplasty and Stenting
- Chapter Fifty Six Endovascular Treatment of Acute Ischemic Stroke
- Chapter Fifty Seven Brain Aneurysm Treatment
- Chapter Fifty Eight Medical and Surgical Treatments of Intracerebral Hemorrhage
- Chapter Fifty Nine Treatment of Vascular Malformations
- Part IV Stroke Literature, Organizations, and Patients
- Index
- References
Summary
Although thrombotic cerebral complications were reported as early as 1825, it was almost 120 years later when the first scientific record of a treatment attempt was published [1]. This record, written by a British gynecologist, Frederick Ross Stansfield, included two case reports and started a discussion that continued during the decades that followed.
- Type
- Chapter
- Information
- Stories of StrokeKey Individuals and the Evolution of Ideas, pp. 505 - 514Publisher: Cambridge University PressPrint publication year: 2022
References
Notes and References
Ribes, MF. Des recherches faites sur la phlebite. In Revue Médicale Francaise et Etrangere et Journal de Clinique de l’Hotel-Dieu et de la Charité de Paris. 1825, vol. 3, pp. 5–41.Google Scholar
Plarr’s Lives of the Fellows. Frederick Ross Stansfield. The Royal College of Surgeons of England. Available at https://livesonline.rcseng.ac.uk/client/en_GB/lives/search/detailnonmodal/ent:$002f$002fSD_ASSET$002f0$002fSD_ASSET:379868/one.Google Scholar
Stansfield, FR. Puerperal cerebral thrombophlebitis treated by heparin. Br. Med. J. 1942;1(4239):436–438.Google Scholar
Ronald Arthur Jones. Royal College of Physicians. Available at https://history.rcplondon.ac.uk/inspiring-physicians/ronald-arthur-jones.Google Scholar
Crafoord, C. Preliminary report on post-operative treatment with heparin as a preventive of thrombosis. Acta Chir. Scand. 1937(79):407–426.Google Scholar
Van Creveld, S, De Bruyne, JI, Stronk, MG. [Thrombosis of the superior sinus longitudinalis in an infant treated with heparin and intravenous fluid supply]. Ned. Tijdschr. Geneeskd. 1949;93(15):1144–1148.Google Scholar
Holub, K. [Intracranial venous thrombosis and thrombophlebitis]. Wien Klin. Wochenschr. 1953;65(26):540–541.Google Scholar
Cairns, DR, Melton, G. Thrombosis of cerebral veins in the puerperium. Br. Med. J. 1942;1(4239):439.CrossRefGoogle ScholarPubMed
Ehrenmitgliedschaft Prof. Dr. Karl Max Einhäupl. Charite – Universitätsmedizin Berlin. Available at https://alumni.charite.de/start_unterseiten/prof_dr_k_m_einhaeupl_ehrenmitglied/.Google Scholar
Einhäupl, KM, Villringer, A, Meister, W, Mehraein, S, Garner, C, Pellkofer, M, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338(8767):597–600.Google Scholar
Stam, J, Lensing, AWA, Vermeulen, M, Tijssen, JGP. Heparin treatment for cerebral venous and sinus thrombosis. Lancet 1991;338(8775):1154.CrossRefGoogle ScholarPubMed
Vermeulen, M, Stam, J, Hijdra, A, van Gijn, J. In memoriam Prof. Dr. H. van Crevel. August 26, 2002. Available at www.ntvg.nl/artikelen/memoriam-profdrhvan-crevel/volledig.Google Scholar
Based on an interview with Prof. dr. Jan Stam.Google Scholar
de Bruijn, SF, Stam, J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30(3):484–488.Google Scholar
Coutinho, JM, Stam, J. How to treat cerebral venous and sinus thrombosis. J. Thromb. Haemost. 2010;8(5):877–883.Google Scholar
Stam, J, De Bruijn, SF, DeVeber, G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002(4):Cd002005.Google ScholarGoogle ScholarGoogle Scholar
Bousser, MG. Cerebral venous thrombosis: Nothing, heparin, or local thrombolysis? Stroke 1999;30(3):481–483.Google Scholar
Bousser, MG, Eschwege, E, Haguenau, M. Aspirin and stroke prevention. Lancet 1988;1(8578):179.CrossRefGoogle ScholarPubMed
Cabut, S. Marie-Germaine Bousser, reine de la neurologie. Le Monde, January 3, 2013. Available at www.lemonde.fr/sciences/article/2013/01/03/marie-germaine-bousser-reine-de-la-neurologie_1812632_1650684.html.Google Scholar
The Brain Prize: Marie-Germaine Bousser. Lundbeckfonden. Available at https://lundbeckfonden.com/marie-germaine-bousser. The education and career of Dr. Bousser is also included in Chapter 21.Google Scholar
Ferro, JM, Canhão, P, Stam, J, Bousser, MG, Barinagarrementeria, F. Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35(3):664–670.CrossRefGoogle Scholar
Einhäupl, K, Stam, J, Bousser, MG, De Bruijn, SF, Ferro, JM, Martinelli, I, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur. J. Neurol. 2010;17(10):1229–1235.CrossRefGoogle ScholarPubMed
The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N. Engl. J. Med. 1997;337(10):657–662.Google ScholarGoogle Scholar
Coutinho, JM, Seelig, R, Bousser, MG, Canhão, P, Ferro, JM, Stam, J. Treatment variations in cerebral venous thrombosis: An international survey. Cerebrovasc. Dis. 2011;32(3):298–300.Google Scholar
Vines, FS, Davis, DO. Clinical-radiological correlation in cerebral venous occlusive disease. Radiology 1971;98(1):9–22.CrossRefGoogle ScholarPubMed
Di Rocco, C, Iannelli, A, Leone, G, Moschini, M, Valori, VM. Heparin-urokinase treatment in aseptic dural sinus thrombosis. Arch. Neurol. 1981;38(7):431–435.CrossRefGoogle ScholarPubMed
Scott, JA, Pascuzzi, RM, Hall, PV, Becker, GJ. Treatment of dural sinus thrombosis with local urokinase infusion: Case report. J. Neurosurg. 1988;68(2):284–287.Google Scholar
Kim, SY, Suh, JH. Direct endovascular thrombolytic therapy for dural sinus thrombosis: Infusion of alteplase. AJNR Am. J. Neuroradiol. 1997;18(4):639–645.Google ScholarPubMed
Caso, V, Billeci, AM, Leys, D. Interventional neuroradiology in the treatment of cerebral venous thrombosis. Front. Neurol. Neurosci. 2008;23:144–160.Google Scholar
Coutinho, JM, van den Berg, R, Zuurbier, SM, Majoie, CB, Stam, J. Mechanical thrombectomy cannot be considered as first-line treatment for cerebral venous thrombosis. J. Neurointerv. Surg. 2013;5(6):621–622.Google Scholar
Stam, J, Majoie, CB, van Delden, OM, van Lienden, KP, Reekers, JA. Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: A prospective study. Stroke 2008;39(5):1487–1490.Google Scholar
Coutinho, JM, Zuurbier, SM, Bousser, MG, Ji, X, Canhão, P, Roos, YB, et al. Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: The TO-ACT randomized clinical trial. JAMA Neurol. 2020;77(8):966–973.Google Scholar
Canhão, P, Ferro, JM, Lindgren, AG, Bousser, MG, Stam, J, Barinagarrementeria, F. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36(8):1720–1725.CrossRefGoogle ScholarPubMed
Ferro, JM, Bousser, M-G, Canhão, P, Coutinho, JM, Crassard, I, Dentali, F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. European J. Neurol. 2017;24(10):1203–1213.Google Scholar
Milandre, L, Gueriot, C, Girard, N, Ali Cherif, A, Khalil, R. [Cerebral venous thrombosis in adults. Diagnostic and therapeutic aspects in 20 cases]. Ann. Med. Interne (Paris) 1989;139(8):544–554.Google ScholarPubMed
Riva, N, Carrier, M, Gatt, A, Ageno, W. Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey. Res. Pract. Thromb. Haemost. 2020;4(7):1192–1202.Google Scholar
Ferro, JM, Coutinho, JM, Dentali, F, Kobayashi, A, Alasheev, A, Canhão, P, et al. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: A randomized clinical trial. JAMA Neurol. 2019;76(12):1457–1465.Google Scholar
Lurkin, A, Derex, L, Fambrini, A, Bertoletti, L, Epinat, M, Mismetti, P, et al. Direct oral anticoagulants for the treatment of cerebral venous thrombosis. Cerebrovasc. Dis. 2019;48(1–2):32–37.Google Scholar